Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 4/20 | 0.56 |
| ▸ | RELA | Q04206 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | FBP1 | P09467 | 1/20 | 0.48 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL888505 | 1.00 | NFE2L2 (0.56) | NFE2L2RELACA1CYP2A6FBP1 | |
| SCHEMBL8447454 | 1.00 | NFE2L2 (0.56) | NFE2L2RELACA1CYP2A6FBP1 | |
| SCHEMBL3389003 | 0.88 | CYP3A4 (0.55) | NFE2L2RELACA1CYP2A6FBP1 | |
| SCHEMBL11212004 | 0.87 | MAOB (0.42) | NFE2L2RELACA1ALOX5ALDH1A1 | |
| SCHEMBL11211999 | 0.87 | MAOB (0.42) | NFE2L2RELACA1ALOX5ALDH1A1 | |
| SCHEMBL11209918 | 0.87 | MAOB (0.42) | NFE2L2RELACA1ALOX5ALDH1A1 | |
| (E)-1,2-Di-P-Tolylethene SCHEMBL1793692 | 0.84 | NFE2L2 (0.74) | NFE2L2RELACA1CYP2A6FBP1 | |
| (E)-1,2-Di-P-Tolylethene SCHEMBL1305582 | 0.84 | NFE2L2 (0.74) | NFE2L2RELACA1CYP2A6FBP1 | |
| SCHEMBL318786 | 0.84 | NFE2L2 (0.74) | NFE2L2RELACA1CYP2A6FBP1 | |
| (E)-1,2-Di-P-Tolylethene SCHEMBL1305580 | 0.84 | NFE2L2 (0.74) | NFE2L2RELACA1CYP2A6FBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220396591-A1 | METHOD FOR PREPARING ALKENYL AMINOBORANES AND THEIR DERIVATIVES, AND USES THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2022-12-15 | — | — | US | disclosed |
| CN-101781262-A | Method for preparing 4-aryl-1H-1,2,3-triazole | UNIV TONGJI | 2010-07-21 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220396591-A1 | METHOD FOR PREPARING ALKENYL AMINOBORANES AND THEIR DERIVATIVES, AND USES THEREOF | CTBP2, HBG2, BCL9L | NFE2L2 1121/4885RELA 4179/4885CA1 3366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.